Evidence map›Paper›PMID 39850338›Full record

ArticleF1000Research2023

Phenotypic and genetic extended spectrum beta lactamase profiles of bacterial isolates from ICU in tertiary level hospital in Kenya.

Job Mwale, Edwin O Magomere, Brian Maina, Leon Otieno, Frank G Onyambu, Ali Kassim, Lucy Muchiri

Abstract read
In one paragraph

Article in F1000Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Job MwaleDepartment of Laboratory Medicine, Kenyatta National Hospital, Nairobi, Nairobi County, Kenya.ORCID 0009-0002-4429-201X
Edwin O MagomereDepartment of Biochemistry and Molecular Biology, Egerton University, Nakuru, Nakuru County, Kenya.ORCID 0000-0002-7735-1576
Brian MainaCentre of Microbiology, Washington State University, Nairobi, Nairobi county, Kenya.ORCID 0000-0002-4992-6838
Leon OtienoDepartment of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Nairobi County, Kenya.
Frank G OnyambuDepartment of Medical Laboratory Sciences, Meru University, Meru, Meru county, Kenya.ORCID 0000-0002-1195-8762
Ali KassimDepartment of Laboratory Medicine, Kenyatta National Hospital, Nairobi, Nairobi County, Kenya.
Lucy MuchiriDepartment of Human Pathology, University of Nairobi, Nairobi, Nairobi County, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bacterial infections in the Intensive Care Units are a threat to the lives of critically ill patients. Their vulnerable immunity predisposes them to developing bacteria-associated sepsis, deteriorating their already fragile health. In the face of increasing antibiotics resistance, the problem of bacterial infection in ICU is worsening. Surveillance of bacterial infections in ICUs and drug resistance will help to understand the magnitude of the problem it poses and inform response strategies. We assessed bacterial infections in ICU setting by identifying prevalent Gram-negative bacterial species and characterized their antibiotic susceptibility patterns. Methods: Cross-sectional samples collected from Kenyatta National Hospital ICU between January and June 2021 were cultured and phenotypic identification of culture-positive samples performed using VITEK 2. Antibiotic susceptibility patterns were determined based on Antimicrobial Susceptibility Testing (AST) results. Cephalosporin-resistant Gram-negative bacteria were assessed by PCR to detect the presence of ESBL genes including ( Results and discussion: Out of the 168 Gram-negative isolates, Conclusion: A high rate of phenotypic and genetic resistance was detected among the tested isolates. Resistance to cephalosporins was primarily driven by acquisition of the ESBL genes. The high prevalence rate of ESBL genes in ICU bacterial isolates shown in this study has a important implication for ICU patient management and general antibiotics use.

Indexed as

beta-LactamasesGram-Negative BacteriaIntensive Care UnitsAnti-Bacterial AgentsCross-Sectional StudiesDrug Resistance, BacterialHumansKenyaMicrobial Sensitivity TestsPhenotypeTertiary Care CentersAnti-Bacterial Agentsbeta-Lactamasesanti-biotic susceptibilitycephalosporinsExtended Spectrum Beta Lactamasegram-negativeIntensive Care Unit

Identifiers

PMID39850338
PMCPMC11754949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.